USE OF LABETALOL IN HYPERTENSIVE PATIENTS DURING DISCONTINUATION OF CLONIDINE THERAPY

被引：19

作者：

ROSENTHAL, T ^{[1
]}

RABINOWITZ, B ^{[1
]}

BOICHIS, H ^{[1
]}

ELAZAR, E ^{[1
]}

BRAUNER, A ^{[1
]}

NEUFELD, HN ^{[1
]}

机构：

[1] TEL AVIV UNIV,CHAIM SHEBA MED CTR,CHAIM SHEBA MED CTR,PEDIAT RENAL UNIT,TEL HASHOMER,ISRAEL

来源：

关键词：

D O I：

10.1007/BF00618771

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：237 / 240

页数：4

共 25 条

[21]

STRANGE RC, 1974, EUR J CLIN INVEST, V4, P115, DOI 10.1111/j.1365-2362.1974.tb02323.x

[22] REBOUND PHENOMENON DURING GRADUAL WITHDRAWAL OF CLONIDINE [J].

VANHOLDER, R ;

CARPENTIER, J ;

SCHURGERS, M ;

CLEMENT, DL .

[23] CLONIDINE AND PROPRANOLOL PARADOXICAL HYPERTENSION [J].

WARREN, SE ;

EBERT, E ;

SWERDLIN, AH ;

STEINBERG, SM ;

STONE, R .

[24]

WEBSTER J, 1974, LANCET, V2, P1381

[25] ABRUPT CESSATION OF CLONIDINE ADMINISTRATION - PROSPECTIVE-STUDY [J].

WHITSETT, TL ;

CHRYSANT, SG ;

DILLARD, BL ;

ANTON, AH .